Target Audience:

Physicians and physician assistants who provide primary care for men, as well as pharmacists and other health care professionals with an interest in testosterone deficiency.

Statement of Need

Testosterone deficiency (TD) affects approximately 30% of men aged 40 – 79 years. The disorder and use of testosterone (T) repletion to treat it have largely has been largely thought of in terms of the sexual ramifications; however, there are critical implications for low T’s role in broader men's health concerns, including metabolic, body composition, and all-cause mortality. Low T is associated with obesity, hypertension, and diabetes. To provide optimal care for middle-aged and older men, primary care clinicians need to possess working knowledge about the pathophysiology of testosterone deficiency and its associated comorbidities. Clinicians then need to match this knowledge with clinical competence in detecting the condition and employing effective treatments.

This CME Outfitters Snack features expert faculty discussing relevant clinical studies and practical recommendations for diagnosing and treating TD, including a review of treatment strategies and an exploration of areas of clinical uncertainty and unmet needs in physician education.

  1. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011:124(7):578-587. PMID: 21683825.
  2. Bhasin S, Cunningham GR, Hayes SJ, et al; Task Force, Endocrine Society. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. PMID: 20525905.

Activity Goal

To educate primary care clinicians on evidence-based strategies aimed at improving the detection and treatment of testosterone deficiency for better overall men’s health.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, AbbVie Inc., and Lilly USA, LLC do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Accreditation:

ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-13-006-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST770 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Credit Designation:

CME Outfitters, LLC designates this continuing education activity for 0.5 contact hour (0.[+ADD NUMBER+] CEUs) of the Accreditation Council for Pharmacy Education. Universal Program Number: 0376-0000-12-017-H01-P

Activity Type: knowledge-based

Faculty Listing:

Culley C. Carson, III, MD, FACS(Moderator)
Rhodes Distinguished Professor of Urology
University of North Carolina
Chapel Hill, NC

Martin M. Miner, MD
Associate Professor of Family Medicine and Urology
Warren Alpert School of Medicine of Brown University
Co-Director, Center of Men's Health
The Miriam Hospital
Providence, RI

Objectives:

  • Counsel men considering treatment for testosterone deficiency on evidence-based treatment options
  • Monitor men being treated for testosterone deficiency for treatment response, side effects, and adherence to therapy, as recommended in guidelines.

Financial Disclosure:

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Carson has disclosed that he received grant and research support from Auxilium Pharmaceuticals, Inc. He serves on the speakers bureaus of American Medical Systems, Inc. (AMS); Auxilium Pharmaceuticals, Inc.; Eli Lilly and Company; and GlaxoSmithKline. Dr. Carson serves as a consultant for American Medical Systems, Inc. (AMS) and Auxilium Pharmaceuticals, Inc.

Dr. Miner has no disclosures to report.

Jeffrey Helfand, DO, MS (peer review) has no disclosures to report.

Monique Johnson, MD CCMEP (planning committee) has no disclosures to report.

Joy B. Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.

Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.